Cala Health is a bioelectronic medicine company that has developed the Cala kIQ™ System, an FDA-cleared, wearable device designed to provide temporary relief of hand tremors in adults with essential tremor and Parkinson’s disease. The device delivers Transcutaneous Afferent Patterned Stimulation (TAPS™) therapy through a wrist-worn interface, non-invasively stimulating the peripheral nervous system to reduce tremor symptoms. Clinical studies have demonstrated the effectiveness of TAPS therapy in alleviating hand tremors, with many users experiencing significant improvements in daily activities. The Cala kIQ System is covered by Medicare for qualifying patients and is also available through the Veterans Affairs (VA) Health System at no cost to VA beneficiaries. Cala Health is headquartered in the San Francisco Bay Area and is committed to advancing wearable neuromodulation therapies to improve patient outcomes. (February 2025)